The Role of Apigenin in NAD+ Metabolism and CD38 Inhibition

内容目录

Introduction: The Hidden Culprit Behind NAD+ Decline

NAD+ is essential for mitochondrial function, energy metabolism, and cellular repair. However, as we age, NAD+ levels decline dramatically—not just due to decreased synthesis, but also increased degradation. One of the main culprits behind this loss is an enzyme called CD38, which consumes NAD+ at a rapid rate. Recent research has shown that Apigenin, a naturally occurring flavonoid, may inhibit CD38 and support NAD+ restoration. This article explores the science behind this mechanism and its potential application in anti-aging supplements.


What Is CD38 and Why It Matters

CD38 is a multifunctional ectoenzyme found on immune and inflammatory cells. While it plays roles in calcium signaling and immune regulation, it also catalyzes the breakdown of NAD+ into nicotinamide and ADP-ribose.

  • With Age: CD38 expression increases with age and chronic inflammation
  • Impact on NAD+: CD38 is a major consumer of NAD+, depleting its cellular reserves
  • Problem: Lower NAD+ levels impair mitochondrial efficiency, DNA repair, and sirtuin activity

Scientific Reference: A pivotal study by Camacho-Pereira et al. (2016, Nature Metabolism) identified CD38 as a key enzyme responsible for age-related NAD+ decline in mammalian tissues.


Apigenin: The CD38 Inhibitor

Apigenin is a flavonoid found in chamomile, parsley, and celery. It’s known for its anti-inflammatory, antioxidant, and neuroprotective properties. In recent years, researchers discovered its ability to suppress CD38 expression and activity.

  • Mechanism of Action:
    • Downregulates CD38 mRNA expression
    • Directly inhibits CD38 enzymatic activity
  • Dual Benefit: Slows NAD+ degradation and supports immune modulation
  • Additional Benefits:
    • Reduces inflammatory cytokines
    • Enhances neurogenesis and cognitive function

Key Study: Chini et al. (2020, FASEB Journal) demonstrated that apigenin significantly reduced CD38 activity in vitro and restored NAD+ levels in aged mice.


Combining Apigenin with NAD+ Precursors

Inhibiting NAD+ consumption is only half the equation; boosting NAD+ synthesis completes the strategy. Combining Apigenin with NMN or NR (Nicotinamide Riboside) may offer synergistic effects.

  • NMN + Apigenin: NMN raises NAD+ levels; Apigenin preserves them by blocking CD38
  • Ideal for:
    • Aging individuals with chronic inflammation
    • Formulas targeting energy, longevity, and cognitive support
  • Formulation Insight: Use liposomal or sustained-release apigenin (98%) for bioavailability

Safety and Regulatory Status

Apigenin is generally recognized as safe (GRAS) and has a long history of use in traditional herbal remedies. It’s currently being studied in clinical trials for its neuroprotective and anti-inflammatory potential.

  • Toxicity: Low toxicity profile in rodent models even at high doses
  • Availability: Readily available from botanical extracts
  • Regulatory Note: No current restrictions for use in dietary supplements in US/EU markets

Conclusion: A Flavonoid with Functional Impact

Apigenin stands out not just for its antioxidant properties, but for its strategic role in preserving NAD+ levels through CD38 inhibition. When paired with NAD+ precursors like NMN, it forms a compelling, science-backed duo for energy, anti-aging, and cellular longevity formulas. For brands and formulators seeking innovation beyond basic antioxidants, apigenin represents a powerful, mechanism-driven option.


📙 Related Articles

Ask For A Quick Quote

We will contact you within 1 working day, please pay attention to the email with the suffix “forrest@oriherb.com”